Home
Vaxxas

Vaxxas Market Share Analysis for August 2026

vaxxas is commercializing a novel needle-free vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.

Health > Biotechnology and Pharmaceuticals

Domainvaxxas.com

Year Founded2011

Employees51 - 200

Annual Revenue$75M - $100M

Vaxxas

Vaxxas (including company regionals)

vaxxas.com

See more website traffic and engagement information

Vaxxas Revenue up to August 2026 is 75M - 100M

revenue generated by Vaxxas top domains

Vaxxas top domains revenue over 3 years

Revenue for Vaxxas top domains

vaxxas.com75M - 100M

See more with Sales Intelligence

Total visits to Vaxxas's top domains

Understand Vaxxas market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

vaxxas.com2.8K

See more with Sales Intelligence

Avg. visit duration in Vaxxas's top domains

Analyze Vaxxas engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

vaxxas.com00:00:08

See more with Sales Intelligence

Avg. pageviews on Vaxxas's top domains

See how Vaxxas keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

vaxxas.com1.42

See more with Sales Intelligence

Vaxxas top competitors by domain

Top similar sites in August 2026, ranked by their affinity

whiteoakpediatrics.comCompany NameWhite Oak PediatricsEmployees51 - 200HQUnited States, Maryland, Silver SpringAnnual revenue$15M - $25MTotal visits4.6KHealth > Health - Other

Top technologies used by Vaxxas

These are the website technologies, by industry, used by Vaxxas top domains

Content Management System (3)

Sitefinity

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

Audio Video Media (1)

YouTube

More Technologies

5

See all

News & Signals from Vaxxas

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsVaxxas, Inc. is developing vaccine delivery systems.Companies like Vaxxas are working on innovative vaccine delivery systems that eliminate the need for traditional needles, signaling a potential shift in the long-term market landscape.

NewsProfenso integrates with Vaxxas, Inc..Manufactured in an aseptic (sterile) environment, the HD-MAP technology requires precise, stringent controls to ensure every patch meets safety and performance standards - the integration of Profenso's AI vision technology into Vaxxas's production workflows aims to introduce real-time insights, automated quality evaluation and improved traceability across critical manufacturing steps.

NewsSK Bioscience partnered with Vaxxas, Inc. on Jan 1st '11.SK bioscience will also collaborate with Vaxxas for the clinical development, with Vaxxas manufacturing HD-MAP vaccines.